Article

Predicting the in vivo mechanism of action for drug leads using NMR metabolomics.

ACS Chemical Biology (Impact Factor: 5.44). 01/2012; 7(1):166-71. DOI: 10.1021/cb200348m
Source: PubMed

ABSTRACT New strategies are needed to circumvent increasing outbreaks of resistant strains of pathogens and to expand the dwindling supply of effective antimicrobials. A common impediment to drug development is the lack of an easy approach to determine the in vivo mechanism of action and efficacy of novel drug leads. Toward this end, we describe an unbiased approach to predict in vivo mechanisms of action from NMR metabolomics data. Mycobacterium smegmatis, a non-pathogenic model organism for Mycobacterium tuberculosis, was treated with 12 known drugs and 3 chemical leads identified from a cell-based assay. NMR analysis of drug-induced changes to the M. smegmatis metabolome resulted in distinct clustering patterns correlating with in vivo drug activity. The clustering of novel chemical leads relative to known drugs provides a mean to identify a protein target or predict in vivo activity.

0 Bookmarks
 · 
129 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT One of the major hurdles in treating tuberculosis (TB) is the time-consuming and difficult methodology for diagnosis. Stable-isotope breath tests hold great potential for rapidly diagnosing an infectious disease, monitoring therapy, and determining a bacterial phenotype in a rapid, point-of-care manner that does not require invasive sampling. Here we describe the preclinical development of a potentially highly selective TB diagnostic breath test based upon the organism's CO dehydrogenase activity. After development of the test in vitro, we were able to use the breath test to discriminate between infected and control rabbits, demonstrating that a diagnosis can potentially be made and also that a complex bacterial phenotype can be noninvasively and rapidly studied in the host. IMPORTANCE Tuberculosis (TB) remains a major infectious cause of disease and death worldwide, and effective diagnosis and then treatment are the tools with which we fight TB. The more quickly and more specific the diagnosis can be made, the better, and this is also true of diagnosis being as close to the patient (point of care) as possible. Here we report our preclinical development of breath tests based upon specific mycobacterial metabolism that could, with development, allow rapid point-of-care diagnosis through measuring the mycobacterial conversion of labeled CO to labeled CO2.
    mBio 01/2014; 5(2). · 6.88 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tuberculosis (TB), caused by Mycobacterium tuberculosis is a highly infectious disease, responsible for 1.4 million deaths annually. Unfortunately, the latest reports of treatment outcomes for patients using the current anti-TB drugs are disappointing, considering the high treatment failure rates. This has been ascribed to a number of factors, including, amongst others: (1) variable individual metabolism (including xenobiotic metabolism, drug malabsorption and drugdrug interactions), (2) drug resistance by the infectious organism and (3) non-adherence to the treatment program, especially due to the associated drug side-effects. Despite this however, only two new drugs have been approved by the FDA since 1962. Thus, it is clear that new strategies are needed for the better elucidation of in vivo anti-TB drug mechanisms and their associated side-effects, and the mechanisms by which the infectious organism develops drug resistance. To this end, the relatively new research approach termed ‘metabolomics’, shows promising results through its capacity for identifying new drug markers, or metabolic pathways related to these contributing factors. Metabolomics refers to the unbiased identification and quantification of all metabolites (products of bio-molecular processes) present in a biological system, using highly selective and sensitive analytical methods. The application of metabolomics, for biomarker discovery, is based on the principle that an external stimulus, such as TB disease or infection, an anti-TB drug, or a mutation resulting in drug resistance, may disrupt normal metabolism, altering the overall physiological status of an organism or host, and these metabolic changes are specific to the perturbation investigated and not due to overall inflammation or disease process. Analyses of these altered metabolic pathways, may subsequently shed new light on the mechanisms associated with the causes of treatment failure, and ultimately lead to new treatment strategies which may most likely be aimed at targeting specific metabolic pathways in M. tuberculosis, and/or the genes/proteins associated with these.
    Current Metabolomics. 01/2013; 1(4).
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Isonitrosoacetophenone (INAP, 2-keto-2-phenyl-acetaldoxime) is a novel inducer of plant defense. Oxime functional groups are rare in natural products, but can serve as substrates depending on existing secondary pathways. Changes in the metabolomes of sorghum and tobacco cells treated with INAP were investigated and chemometric tools and multivariate statistical analysis were used to investigate the changes in metabolite distribution patterns resulting from INAP elicitation. Liquid chromatography combined with mass spectrometry (UHPLC-MS) supplied unique chemical fingerprints that were generated in response to specific metabolomic events. Principal component analysis (PCA) together with hierarchical cluster analysis (HCA) and Metabolic Trees were used for data visualization. Orthogonal projections to latent structures discriminant analysis (OPLS-DA) and shared and unique structure (SUS) plots were exploited in parallel to reveal the changes in the metabolomes. PCA indicated that the cells responded differentially to INAP through changes in the metabolite profiles. Furthermore, HCA and Metabolic Trees showed that INAP induced metabolic perturbations in both cell lines and that homeostasis was re-established over time. OPLS-DA-based shared and unique structure (SUS) plots confirmed the results and revealed differences in the metabolites distribution patterns between tobacco and sorghum cells. Chemometric analyses of metabolomic data offers insight into changes in metabolism in response to chemical elicitation. Although similar, the response in sorghum cells was found to be more consistent and well-coordinated when compared to tobacco cells, indicative of the differences in secondary metabolism between cyanogenic and non-cyanogenic plants for oxime metabolism.
    SpringerPlus 06/2014; 3:254.

Full-text

Download
1 Download
Available from